Download Free The Politics Of Biotechnology In North America And Europe Book in PDF and EPUB Free Download. You can read online The Politics Of Biotechnology In North America And Europe and write the review.

Biotechnology is one of the most important new issues to emerge in the knowledge economy. The Politics of Biotechnology in North America and Europe provides analysts with a perspective on policy-making in scientifically advanced countries that integrate the insights of several approaches and that display a particular sensitivity to the complexity of policy-making conjectures. This perspective allows going beyond the simplistic understandings of biotechnology policy currently prevailing. This volume provides a rigorous analysis and detailed information on biotechnology policy in nine countries. The essays included here present the results of in-depth empirical research in the area of biomedicine and agro-food biotechnology. The book is, therefore, not only of interest to policy-makers and policy analysts, but also to anyone with an interest in biotechnology.
Interest in the study of kinship, a key area of anthropological enquiry, has recently reemerged. Dubbed 'the new kinship', this interest was stimulated by the 'new genetics' and revived interest in kinship and family patterns. This volume investigates the impact of biotechnology on contemporary understandings of kinship, of family and 'belonging' in a variety of European settings and reveals similarities and differences in how kinship is conceived. What constitutes kinship for different publics? How significant are biogenetic links? What does family resemblance tell us? Why is genetically modified food an issue? Are 'genes' and 'blood' interchangeable? It has been argued that the recent prominence of genetic science and genetic technologies has resulted in a 'geneticization' of social life; the ethnographic examples presented here do show shifts occurring in notions of 'nature' and of what is 'natural'. But, they also illustrate the complexity of contemporary kinship thinking in Europe and the continued interconnectedness of biological and sociological understandings of relatedness and the relationship between nature and nurture.
Biotechnology and the Politics of Plants explores the mysterious phenomenon of ‘apomixis’, the ability of certain plants to ‘self-clone’, and its potential as a revolutionary tool for agriculture and enhancing food security, that may soon be a reality. Through historical anthropological and ethnographic study, Matt Hodges traces the development of the CIMMYT Apomixis Project, a prominent frontier research initiative, and its reinvention as a leading public-private partnership. He analyzes the fast-moving historical transition from public sector, mixed plant breeding approaches grounded in genetics, to a contemporary era of agricultural biotechnology and genomics where PPPs are a leading format, and explores how social contexts of research shape how knowledge is produced, as well as what remains ‘unknown’, and constrain the development of an ‘Apomixis Technology’. The chapters present an inventive approach informed by the anthropology of time, science and technology studies, and dialogue with the work of Gilles Deleuze, Paul Rabinow, Hannah Arendt, Andrew Pickering, and Eduardo Viveiros de Castro. Hodges outlines novel ways of integrating notions of history and becoming, and considers how apomixis offers up an alternative image of thought to theoretical concepts such as the well-known ‘rhizome’. The book makes a valuable contribution to both the growing social scientific literature on genomics and biotechnology, and recent anthropological debates on time and history.
Biotechnology is one of the most important new issues to emerge in the knowledge economy. The Politics of Biotechnology in North America and Europe provides analysts with a perspective on policy-making in scientifically advanced countries that integrate the insights of several approaches and that display a particular sensitivity to the complexity of policy-making conjectures. This perspective allows going beyond the simplistic understandings of biotechnology policy currently prevailing. This volume provides a rigorous analysis and detailed information on biotechnology policy in nine countries. The essays included here present the results of in-depth empirical research in the area of biomedicine and agro-food biotechnology. The book is, therefore, not only of interest to policy-makers and policy analysts, but also to anyone with an interest in biotechnology.
Biology and politics have converged today across much of the industrialized world. Debates about genetically modified organisms, cloning, stem cells, animal patenting, and new reproductive technologies crowd media headlines and policy agendas. Less noticed, but no less important, are the rifts that have appeared among leading Western nations about the right way to govern innovation in genetics and biotechnology. These significant differences in law and policy, and in ethical analysis, may in a globalizing world act as obstacles to free trade, scientific inquiry, and shared understandings of human dignity. In this magisterial look at some twenty-five years of scientific and social development, Sheila Jasanoff compares the politics and policy of the life sciences in Britain, Germany, the United States, and in the European Union as a whole. She shows how public and private actors in each setting evaluated new manifestations of biotechnology and tried to reassure themselves about their safety. Three main themes emerge. First, core concepts of democratic theory, such as citizenship, deliberation, and accountability, cannot be understood satisfactorily without taking on board the politics of science and technology. Second, in all three countries, policies for the life sciences have been incorporated into "nation-building" projects that seek to reimagine what the nation stands for. Third, political culture influences democratic politics, and it works through the institutionalized ways in which citizens understand and evaluate public knowledge. These three aspects of contemporary politics, Jasanoff argues, help account not only for policy divergences but also for the perceived legitimacy of state actions.
Introduction -- Defining the public interest in the US and European patent systems -- Confronting the questions of life-form patentability -- Commodification, animal dignity, and patent-system publics -- Forging new patent politics through the human embryonic stem cell debates -- Human genes, plants, and the distributive implications of patents -- Conclusion
"The ongoing COVID-19 pandemic marks the most significant, singular global disruption since World War II, with health, economic, political, and security implications that will ripple for years to come." -Global Trends 2040 (2021) Global Trends 2040-A More Contested World (2021), released by the US National Intelligence Council, is the latest report in its series of reports starting in 1997 about megatrends and the world's future. This report, strongly influenced by the COVID-19 pandemic, paints a bleak picture of the future and describes a contested, fragmented and turbulent world. It specifically discusses the four main trends that will shape tomorrow's world: - Demographics-by 2040, 1.4 billion people will be added mostly in Africa and South Asia. - Economics-increased government debt and concentrated economic power will escalate problems for the poor and middleclass. - Climate-a hotter world will increase water, food, and health insecurity. - Technology-the emergence of new technologies could both solve and cause problems for human life. Students of trends, policymakers, entrepreneurs, academics, journalists and anyone eager for a glimpse into the next decades, will find this report, with colored graphs, essential reading.
This book opens up the world on private equity investment in one of the hottest industries – Biotechnology. The book describes how Europe has fallen behind the US due to under-investment and bad management by the VCs who control the companies. Detailed analysis shows why it is in VCs’ interests to damage the very companies they invest in.
Between 1973 and 2016, the ways to manipulate DNA to endow new characteristics in an organism (that is, biotechnology) have advanced, enabling the development of products that were not previously possible. What will the likely future products of biotechnology be over the next 5â€"10 years? What scientific capabilities, tools, and/or expertise may be needed by the regulatory agencies to ensure they make efficient and sound evaluations of the likely future products of biotechnology? Preparing for Future Products of Biotechnology analyzes the future landscape of biotechnology products and seeks to inform forthcoming policy making. This report identifies potential new risks and frameworks for risk assessment and areas in which the risks or lack of risks relating to the products of biotechnology are well understood.
The Biotechnology Act in Norway, one of the most restrictive in Europe, forbids egg donation and surrogacy and has rescinded the anonymity clause with respect to donor insemination. Thus, it limits people's choice as to how they can procreate within the boundaries of the nation state. The author pursues this significant datum ethnographically and addresses the issues surrounding contemporary biopolitics in Norway. This involves investigating such fundamental questions as the relation between individual and society, meanings of kinship and relatedness, the moral status of the embryo and the role of science, religion and ethics in state policies. Even though the book takes reproductive technologies as its focus, it reveals much about vital processes that are central to contemporary Norwegian society.